Abstract
Just like the Internet in 1990’s, Artificial intelligence is now changing all aspects of our life and work. It’s impact is beginning to show in the industry and it is changing the life-sciences practice by fundamentally altering the way how medicines are discovered, developed, manufactured, approved, supplied and brought to market.
In research and discovery, generative models and structure prediction systems shorten the path from target to lead and raise the ceiling…
We are now halfway through 2025, and it’s not too late to highlight the practices and trends that are shaping and will continue to shape the biopharma landscape this year. In 2024, we navigated the 4 biopharma trends that exerted vehement force in the industry and shaped the course of healthcare practices. Last year, the…
Hector De La Riva joins PharmaShots Managing Editor Himanshu Sehgal for a riveting conversation on his recent panel discussion at Reuters Events Pharma 2025. “Reimagine Your 2025 Sales Strategy,” the topic of his panel discussion, examined the ever-evolving commercial landscape and the role of field engagement and customer empowerment in shaping strategic investments.
Hector stresses…
Shots:
2023 had been a great year for the biopharma industry despite several imposed restrictions from the IRA and inflation
With several swaying factors impacting the biopharma industry, including social, economic, regulatory and others, some of the noteworthy trends that emerged in 2024 and are shaping the ways biopharma companies operate
The article explores four key…
Shots:
Kyle started by giving a brief introduction to Model N’s Spring 2023 product release for life sciences and high-tech customers and discussed its key features
He then spoke about the challenges faced by the pharmaceutical industry due to duplicate discounts and how Model N’s 340B Vigilance Solution can address these challenges
The interview shows…

